Literature DB >> 2231932

The natural history of Peyronie's disease.

M K Gelbard1, F Dorey, K James.   

Abstract

The natural history of Peyronie's disease was evaluated in 97 men by means of a questionnaire. Disease duration ranged from 3 months to 8 years. Questions addressed pain, bending, ability for intercourse, over-all effect of the disease, psychological effects, treatments received and degree of disease progression. Approximately 40% of the patients found pain, bending, ability for intercourse and over-all effects to be unchanged during the course of the disease. Bending and ability for relations worsened in 40% of the patients during the same interval, while only 6% had worsening of pain. Of the patients 77% reported psychological effects due to Peyronie's disease, which improved in 28%, did not change in 36% and worsened in 36%. Over-all, 13% of the patients believed the disease to be one of gradual resolution, 47% believed there had been little or no change and 40% believed that the disease pattern was one of gradual progression. We found no statistically significant association between disease duration and spontaneous improvement in penile bending. A similar lack of statistical significance was found when improvement in a variety of categories was compared in patients who received no therapy versus those who received a variety of conventional medical therapies.

Entities:  

Mesh:

Year:  1990        PMID: 2231932     DOI: 10.1016/s0022-5347(17)39746-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  50 in total

1.  Peyronie's disease: epidemiology and clinical presentation of 134 cases.

Authors:  P Perimenis; A Athanasopoulos; K Gyftopoulos; G Katsenis; G Barbalias
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Peyronie's Disease: Nonsurgical Therapy Options.

Authors:  Franklin E Kuehhas; Peter Weibl; Tosev Georgi; Nenad Djakovic; Ralf Herwig
Journal:  Rev Urol       Date:  2011

3.  PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2015-06-01

4.  [Assessment among German urologists of various conservative treatment modalities for Peyronie's disease. Results of a survey].

Authors:  E W Hauck; T Bschleipfer; S M Haag; V Rohde; W Weidner
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

Review 5.  [Peyronie's disease. Conservative and surgical therapy].

Authors:  E W Hauck; T Diemer; W Weidner
Journal:  Urologe A       Date:  2006-02       Impact factor: 0.639

Review 6.  Nonsurgical treatment options in Peyronie's Disease: 2016 update.

Authors:  Raidh A Talib; Mohammed Abdulkareem Ibrahim; Önder Cangüven
Journal:  Turk J Urol       Date:  2016-12

Review 7.  Experience in the use of collagenase clostridium histolyticum in the management of Peyronie's disease: current data and future prospects.

Authors:  María Alejandra Egui Rojo; Ignacio Moncada Iribarren; Joaquín Carballido Rodriguez; Juan Ignacio Martinez-Salamanca
Journal:  Ther Adv Urol       Date:  2014-10

8.  A malignant differential diagnosis for Peyronie's disease.

Authors:  Manoj Kumar Gupta; Swaroop Revannasiddaiah; Sridhar Papaiah Susheela
Journal:  BMJ Case Rep       Date:  2014-04-07

9.  Intralesional hyaluronic acid: an innovative treatment for Peyronie's disease.

Authors:  Romano Gennaro; Davide Barletta; Gianni Paulis
Journal:  Int Urol Nephrol       Date:  2015-08-11       Impact factor: 2.370

10.  The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie's disease.

Authors:  E C Serefoglu; L Trost; S C Sikka; W J G Hellstrom
Journal:  Int J Impot Res       Date:  2014-07-17       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.